Fludarabine (Flu) and IV busulfan (Bu)±ATG:: Low toxicity conditioning regimen for stem cell transplantation (SCT) in AML and MDS -: Preliminary results.

被引：0
|
作者：
deLima, M
Shahjahan, M
Madden, T
Tran, HT
Gajewski, JL
Couriel, DR
Giralt, S
Donato, ML
Anderlini, P
Korbling, M
Khouri, I
Russell, JA
Champlin, RE
Andersson, BS
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Tom Baker Canc Clin, Dept Med, Calgary, AB, Canada
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5147
引用
收藏
页码：345B / 345B
页数：1
相关论文
共 50 条
  • [31] Fludarabine and busulfan as conditioning regimen in allogeneic stem cell transplantation: comparison with BuCy2
    Fedele, R.
    Moscato, T.
    Massara, E.
    Messina, G.
    Iacopino, O.
    Pontari, A.
    Spiniello, E.
    Callea, I.
    Garreffa, C.
    Martino, M.
    Console, G.
    Gallo, G.
    Princi, D.
    Monteleone, R.
    Irrera, G.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S418 - S419
  • [32] Allogeneic (Allo) Stem Cell Transplantation (SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1) with a Reduced Intensity Conditioning (RIC) of Fludarabine (Flu), 2 Day Busulfan (Bu2) and Horse ATG (hATG): The UMass Experience
    Nath, Rajneesh
    Cerny, Jan
    Ramanathan, Muthalagu
    Raffel, Glen
    George, Mridula
    Al-Mansour, Zeina
    Petrillo-Deluca, Laura
    Martin, Tzafra
    Desai, Zankar
    Bednarik, Jayde
    Kroll-Desrosiers, Aimee
    Rosmarin, Alan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S156 - S157
  • [33] Treatment of graft failure with fludarabine (Flu), antithymocyte globulin (ATG) and a second allogeneic stem cell transplantation (SCT).
    Jabbour, EJ
    Shahjahan, M
    Rondon, G
    Anderlini, P
    Giralt, S
    Couriel, DR
    Champlin, RE
    Khouri, IF
    BLOOD, 2005, 106 (11) : 767A - 767A
  • [34] IV busulfan and fludarabine as conditioning regimen therapy for autologous stem cell transplantation in patients with acute non-lymphoid leukaemia
    Console, G.
    Messina, G.
    Moscato, T.
    Martino, M.
    Fedele, R.
    Massara, E.
    Princi, D.
    Monteleone, R.
    Redaelli, G.
    Irrera, G.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S91 - S91
  • [35] BUSULFAN/CYCLOPHOSPHAMIDE VS. BUSULFAN/FLUDARABINE CONDITIONING FOR ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH AML/MDS: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS
    Song, I.
    Ryu, H.
    Choi, Y.
    Lee, H.
    Yun, H.
    Kim, S.
    Jo, D.
    HAEMATOLOGICA, 2013, 98 : 656 - 657
  • [36] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
  • [37] Conditioning regimen with a 75% dose of standard busulfan/cyclophosphamide plus fludarabine before cord blood transplantation in older patients with AML and MDS
    Ohta, Takanori
    Sugio, Yasuhiro
    Imanaga, Hiroshi
    Oku, Seidou
    Ohno, Yuju
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (03) : 347 - 354
  • [38] Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS
    Alatrash, Gheath
    Kidwell, Kelly M.
    Thall, Peter F.
    Di Stasi, Antonio
    Chen, Julianne
    Zope, Madhushree
    Crain, Alyssa K.
    Champlin, Richard E.
    Popat, Uday
    Shpall, Elizabeth J.
    Jones, Roy B.
    Andersson, Borje S.
    BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1245 - 1253
  • [39] Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS
    Gheath Alatrash
    Kelly M. Kidwell
    Peter F. Thall
    Antonio Di Stasi
    Julianne Chen
    Madhushree Zope
    Alyssa K. Crain
    Richard E. Champlin
    Uday Popat
    Elizabeth J. Shpall
    Roy B. Jones
    Borje S. Andersson
    Bone Marrow Transplantation, 2019, 54 : 1245 - 1253
  • [40] Conditioning regimen with a 75% dose of standard busulfan/cyclophosphamide plus fludarabine before cord blood transplantation in older patients with AML and MDS
    Takanori Ohta
    Yasuhiro Sugio
    Hiroshi Imanaga
    Seidou Oku
    Yuju Ohno
    International Journal of Hematology, 2019, 110 : 347 - 354
12345